56
Views
25
CrossRef citations to date
0
Altmetric
Original

Longitudinal Changes in Sexual Risk Behavior Among HIV+ and HIV− Male Injecting Drug Users

, Ph.D., , Dr. rer. nat., , Ph.D., , Ph.D., , Ph.D., , Ph.D., M.P.H., , M.D., , M.D., M.P.H. & , Ph.D. show all
Pages 281-303 | Published online: 05 Dec 1999

REFERENCES

  • New York City Department of Health. AIDS Surveillance Update, Second Quarter 1996, Author, New York, 1996
  • Anderson W. The New York needle trial: The politics of public health in the age of AIDS. AIDS and Contemporary History, V. Berridge, P. Strong. Cambridge University Press, CambridgeEngland 1993; 157–181
  • Friedman S. R., Rosenblum A., Goldsmith D., et al. Risk factors for HIV-1 infection among street-recruited intravenous drug users in New York City, poster session presented at the. Fifth International AIDS Conference, MontrealCanada, June, 1989
  • Battjes R. J., Pickens R. HIV infection among intravenous drug abusers (IVDAs) in five U.S. cities, poster session presented at the. Fourth International AIDS Conference, StockholmSweden, June, 1988
  • Kleinman P. H., Friedman S. R., Goldsmith D. S., et al. HIV seropositivity in a population of street intravenous drug users in New York City in 1987, poster session presented at the. Fourth International AIDS Conference, StockholmSweden, June, 1988
  • Yee K., Brown L. S., Primm B. J., et al. Needle-sharing patterns as a predictor of HIV seroprevalence among New York City intravenous drug users (IVDUs), poster session presented at the. Fifth International AIDS Conference, MontrealCanada, June, 1989
  • Schoenbaum E. E., Selwyn P. A., Hartel D., et al. HIV infection in intravenous drug users in New York City: The relation of drug use and heterosexual behaviors and race/ethnicity, poster session presented at the. Fourth International AIDS Conference, StockholmSweden, June, 1988
  • Nelson A. Rockefeller Institute of Government. The 1994 New York State Statistical Yearbook. New York 1994, Author
  • Clatts M. C., Davis W. R., Deren S., et al. AIDS risk behavior among drug injectors in New York City: Critical gaps in prevention policy. Global AIDS Policy, D. Feldman. Bergin and Garvey, Westport, Connecticut 1994; 215–235
  • Friedman S. R., Des Jarlais D. C., Sotheran J. L., et al. AIDS and self-organization among intravenous drug users. Int. J. Addict. 1987; 22: 201–219
  • Iguchi M. Y., Bux D. A., Jr., Lidz V., et al. Changes in HIV risk behavior among injecting drug users: The impact of 21 versus 90 days of methadone detoxification. AIDS 1996; 10: 1719–1728
  • Camacho L. M., Bartholomew N. G., Joe G. W., et al. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance. Drug Alcohol Depend 1996; 41: 1–7
  • Selwyn P. A., Feiner C., Cox C. P., et al. Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City. AIDS 1987; 1: 247–254
  • Ronald P. J. M., Robertson J. R., Roberts J. J. K. Risk-taking behavior on the decline in intravenous drug users. Br. J. Addict. 1992; 87: 115–116
  • Celentano D. D., Muñoz A., Cohn S., et al. Drug-related behavior change for HIV transmission among American injection drug users. Addiction 1994; 89: 1309–1317
  • van Ameijden E. J. C., van den Hoek A. A. R., Coutinho R. A. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs Am. J. Public Health 1994; 84: 275–281
  • Peters A. D., Reid M. M., Griffin S. G. Edinburgh drug users: Are they injecting and sharing less. AIDS 1994; 8: 521–528
  • Saxon A. J., Calsyn D. A., Jackson T. R. Longitudinal changes in injection behaviors in a cohort of injection drug users. Addiction 1994; 89: 191–202
  • Des Jarlais D. C., Friedman S. R., Choopanya K., et al. International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992; 6: 1053–1068
  • Feucht T. E., Stephens R. C., Roman S. W. The sexual behavior of intravenous drug users: Assessing the risk of sexual transmission of HIV. J. Drug Issues 1990; 20: 195–213
  • McDonald C., Loxley W., Marsh A. A bridge too near? Injecting drug users' sexual behavior. AIDS Care 1994; 6: 317–326
  • Booth R. E., Watters J. K. How effective are risk-reduction interventions targeting injecting drug users. AIDS 1994; 8: 1515–1524
  • Rietmeijer C. A., Kane M. S., Simons P. Z., et al. Increasing use of bleach and condoms among injecting drug users in Denver: Outcome of a targeted community-level HIV prevention program. AIDS 1996; 10: 291–298
  • Deren S., Rees D. W., Beardsley M., et al. Outcomes of a risk-reduction intervention with high-risk populations: The Harlem AIDS project. AIDS Educ. Prev. 1995; 7: 379–390
  • Des Jarlais D. C., Friedman S. R., Friedmann P., et al. HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS 1995; 9: 611–617
  • Des Jarlais D. C., Abdul-Quader A., Tross S. The next problem: Maintenance of AIDS risk reduction among intravenous drug users. Int. J. Addict. 1991; 26: 1279–1292
  • Casadonte P. P., Des Jarlais D. C., Friedman S. R., et al. Psychological and behavioral impact among intravenous drug users of learning HIV test results. Int. J. Addict. 1990; 25: 409–426
  • Davoli M., Perucci C. A., Abeni D. D., et al. HIV risk-related behaviors among injection drug users in Rome: Differences between 1990 and 1992. Am. J. Public Health 1995; 85: 829–832
  • Schilling R. F., El-Bassel N., Gilbert L. Predictors of changes in sexual behavior among women on methadone. Am. J. Drug Alcohol Abuse 1993; 19: 409–422
  • Martin J. L., Dean L., Garcia M., et al. The impact of AIDS on a gay community: Changes in sexual behavior, substance use, and mental health. Am. J. Community Psychol. 1989; 17: 269–293
  • Janz N. K., Becker M. H. The Health Belief Model: A decade later. Health Educ. Q 1984; 11: 1–47
  • Catania J. A., Coates T. J., Kegeles S. A test of the AIDS Risk Reduction Model: Psychosocial correlates of condom use in the AMEN cohort survey. Health Psychol. 1994; 13: 548–555
  • Friedman S. R., Jose B., Neaigus A., et al. Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs. AIDS 1994; 8: 357–361
  • Vanichseni S., Des Jarlais D. C., Choopanya K., et al. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States. AIDS 1993; 7: 887–891
  • Watkins K. E., Metzger D., Woody G. E., et al. Determinants of condom use among intravenous drug users. AIDS 1993; 7: 719–723
  • Skidmore C. A., Robertson J. R., Roberts J. J. Changes in HIV risk-taking behavior in intravenous drug users: A second follow-up. Br. J. Addict. 1989; 84: 695–696
  • Rabkin J. G., Rabkin R., Wagner G. Testosterone replacement therapy in HIV illness. Gen. Hosp. Psychiatry 1995; 17: 37–42
  • Exner T. M., Dolezal C. L., Liu X., et al. Sexual risk behavior in the course of HIV disease: HIV+ versus HIV− gay men, poster session presented at the. Twenty-First Annual Meeting of the International Academy of Sex Research, Provincetown, Massachusetts, September, 1995
  • Report of a Working Group of the American Academy of Neurology AIDS Task Force, Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991; 41: 778–785
  • Budka H., Wiley C. A., Kleihues P., et al. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1991; 1: 143–152
  • Petty R. K. H. Recent advances in the neurology of HIV infection. Postgrad. Med. J. 1994; 70: 393–403
  • Marder K., Liu X., Stern Y., et al. Risk of human immunodeficiency virus type 1-related neurologic disease in a cohort of intravenous drug users. Arch. Neurol. 1995; 52: 1174–1182
  • Stern Y., Liu X., Marder K., et al. Neuropsychological changes in a prospectively followed cohort of intravenous drug users with and without HIV. Neuropsychiatry Neuropsychol. Behav. Neurol. 1996; 9: 83–90
  • Bono G., Mauri M., Sinforiani E., et al. Longitudinal neuropsychological evaluations of HIV-infected intravenous drug users Addiction 1996; 91: 263–268
  • Hestad K., Aukrust P., Ellertsen B., et al. Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users. J. Clin. Exp. Neuropsychol. 1993; 15: 732–742
  • Egan V. G., Crawford J. R., Brettle R. P., et al. The Edinburgh cohort of HIV-positive drug users: Current intellectual function is impaired, but not due to early AIDS dementia complex. AIDS 1990; 4: 651–656
  • Egan V., Brettle R. P., Goodwin G. M. The Edinburgh cohort of HIV-positive drug users: Pattern of cognitive impairment in relation to progression of disease. Br. J. Psychiatry 1992; 161: 522–531
  • Peavy G., Jacobs D., Salmon D. P., et al. Verbal memory performance of patients with human immunodeficiency virus infection: Evidence of subcortical dysfunction. J. Clin. Exp. Neuropsychol. 1994; 16: 508–523
  • Bornstein R. A., Nasrallah H. A., Para M. F., et al. Change in neuropsychological performance in asymptomatic HIV infection: One-year follow-up. AIDS 1993; 7: 1607–1611
  • Lipsitz J. D., Williams J. B. W., Rabkin J. G., et al. Psychopathology in male and female intravenous drug users with and without HIV infection. Am. J. Psychiatry 1994; 151: 1662–1668
  • Rabkin J. G., Johnson J., Lin S.-H., et al. Psychopathology in male and female HIV-positive and negative injecting drug users: Longitudinal course over 3 years. AIDS 1997; 11: 507–515
  • Rabkin J. G. Prevalence of psychiatric disorders in HIV illness. Int. Rev. Psychiatry 1996; 8: 157–166
  • Judd F. K., Mijch A. M. Depression in patients with HIV and AIDS. Aust. N.Z. J. Psychiatry 1994; 28: 642–650
  • Perry S. W. HIV-related depression. HIV, AIDS and the Brain, R. W. Price, S. W. Perry. Raven Press, New York 1994; 223–238
  • Camacho L. M., Brown B. S., Simpson D. D. Psychological dysfunction and HIV/AIDS risk behavior. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995; 11: 198–202
  • Nemoto T., Foster K., Brown L. Effect of psychological factors on risk behavior of human immunodeficiency virus (HIV) infection among intravenous drug users (IVDUs). Int. J. Addict. 1991; 26: 441–456
  • Gorman J. M., Kertzner R., Todak G., et al. Multidisciplinary baseline assessment of gay men with and without HIV infection. I: Overview of study design. Arch. Gen. Psychiatry 1991; 48: 120–123
  • Meyer-Bahlburg H. F. L., Exner T. M., Dellenbaugh C., et al. Sexual identity and sexual risk behavior in intravenous drug using men. The VII International Conference on AIDS. Abstract Book, FlorenceItaly 1991; 1: 398, June 16–21 #M.D.4035 June 1991
  • Meyer-Bahlburg H. F. L., Exner T. M., Dolezal C. L., et al. (1992) Change of sexual risk behavior in IVDU men. The VIII International Conference on AIDS/III STD World Congress, AmsterdamThe Netherlands, July, 19–241992. Poster Abstracts, 2, #PoD 5086, D401 July.
  • Centers for Disease Control, CDC classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR Morb. Mortal. Wkly. Rep. 1986; 35: 334–339
  • Meyer-Bahlburg H. F. L., Exner T. M., Lorenz G., et al. Sexual risk behavior, sexual functioning, and HIV-disease progression in gay men. J. Sex. Res. 1991; 28: 3–27
  • Joseph J. G., Montgomery S., Kessler R., et al. Two-year longitudinal study of behavioral risk reduction in a cohort of homosexual men, poster session presented at the. Third International Conference on AIDS, Washington, D.C., 1987
  • Ostrow D. G. Risk reduction for transmission of human immunodeficiency virus in high-risk communities. Psychiatr. Med. 1989; 7: 79–96
  • Kurtzke J. F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452
  • Buschke H., Fuld P. A. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974; 24: 1019–1025
  • Derogatis L. R., Lipman R. S., Covil L. SCL-90: An outpatient psychiatric rating scale-preliminary report. Psychopharmacol. Bull. 1973; 9: 13–28
  • Liang K. Y., Zeger S. L. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13–22
  • Ross M. W., Kelaher M., Wodak A., et al. Predictors of intoxicated sex in injecting drug users. J. Addict. Dis. 1994; 13: 69–80
  • Longshore D., Anglin M. D., Hseih S., et al. Sexual behaviors and cocaine preference among injection drug users in Los Angeles. J. Drug Issues 1993; 23: 363–374
  • McBride D. C., Inciardi J. A., Chitwood D. D., et al. Crack use and correlates of use in a national population of street heroin users. J. Psychoactive Drugs 1992; 24: 411–416
  • Crenshaw T. L., Goldberg J. P. Sexual Pharmacology: Drugs that Affect Sexual Functioning. W. W. Norton and Company, New York 1996
  • Des Jarlais D. C. Cross-national studies of AIDS among injecting drug users. Addiction 1994; 89: 383–392

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.